Table 1.
Trials | Control Arm | Experimental Arm | Type of Hyperthermia |
---|---|---|---|
NCT01077427 Phase III | Adjuvant Gemcitabine and Capecitabine | Adjuvant Gemcitabine Cisplatin and regional hyperthermia | Regional hyperthermia |
NCT02439593 Phase II | Chemo radiotherapy | Thermo chemo radiotherapy | Regional hyperthermia |
NCT03251365 Phase II and III | Adjuvant chemotherapy Gemcitabine | HIPEC gemcitabine | Hyperthermic intraabdominal chemotherapy |
NCT02862015 Phase II | Folfirinox or gemcitabine-based chemotherapy | Oncothermia | Whole body hyperthermia |
NCT02973217 | Standard chemotherapy | Specific form of thermotherapy—Immuno Stimulating interstitial laser thermotherapy | Thermotherapy |
Note: Pancreatic cancer clinical trials employing hyperthermia with other modalities (radiation/chemotherapy/immunotherapy).